当前位置:首页 - 行情中心 - 海王生物(000078) - 财务分析 - 现金流量表

海王生物

(000078)

  

流通市值:63.55亿  总市值:66.57亿
流通股本:26.26亿   总股本:27.51亿

现金流量表

报告期2023-09-302023-06-302023-03-312022-12-31
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金28,313,286,615.2219,437,445,893.668,938,394,583.7338,542,876,509.48
收到的税费返还9,580,729.437,518,503.4584,426.5641,641,635.01
收到其他与经营活动有关的现金2,208,618,592.371,368,561,287.16854,730,607.512,653,687,844.15
经营活动现金流入的平衡项目0000
经营活动现金流入小计30,531,485,937.0220,813,525,684.229,793,709,617.841,238,205,988.64
购买商品、接受劳务支付的现金25,255,847,361.5717,219,998,817.828,136,260,079.135,286,804,039.8
支付给职工以及为职工支付的现金785,343,099.19518,158,362.03290,052,739.651,056,746,265
支付的各项税费740,566,174.59527,295,230.57231,211,528.06972,847,465.94
支付其他与经营活动有关的现金3,574,881,154.92,331,596,746.151,026,707,284.313,986,136,893.83
经营活动现金流出的平衡项目0000
经营活动现金流出小计30,356,637,790.2520,597,049,156.579,684,231,631.1241,302,534,664.57
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额174,848,146.77216,476,527.65109,477,986.68-64,328,675.93
二、投资活动产生的现金流量:
收回投资收到的现金40,641,106.3820,655,526.132,500,000108,023,018.91
取得投资收益收到的现金1,460,515.841,146,310.9573,750.015,421,517.24
处置固定资产、无形资产和其他长期资产收回的现金净额5,671,655.831,780,258.91378,122.6410,527,240.87
处置子公司及其他营业单位收到的现金净额3,632,300.37-7,144,810.9631,409,526.25
收到的其他与投资活动有关的现金--3,000,064.52-
投资活动现金流入的平衡项目0000
投资活动现金流入小计51,405,578.4223,582,095.9413,596,748.13155,381,303.27
购建固定资产、无形资产和其他长期资产支付的现金75,060,494.6851,314,248.7229,252,319.8694,318,309
投资支付的现金7,317,739.256,317,739.255,500,000166,750,000
取得子公司及其他营业单位支付的现金82,808,677.5262,067,774.8931,319,918169,413,130.24
支付其他与投资活动有关的现金170,000,000160,012,510.59--
投资活动现金流出的平衡项目0000
投资活动现金流出小计335,186,911.45279,712,273.4566,072,237.86430,481,439.24
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-283,781,333.03-256,130,177.51-52,475,489.73-275,100,135.97
三、筹资活动产生的现金流量:
吸收投资收到的现金529,100529,100-27,208,000
其中:子公司吸收少数股东投资收到的现金529,100529,100-27,208,000
取得借款收到的现金13,301,995,964.067,744,746,560.934,000,215,259.217,937,311,721.4
收到其他与筹资活动有关的现金4,588,077,747.963,782,362,784.621,061,704,855.9512,052,962,872.03
筹资活动现金流入平衡项目0000
筹资活动现金流入小计17,890,602,812.0211,527,638,445.555,061,920,115.1620,017,482,593.43
偿还债务支付的现金12,963,750,718.817,133,747,400.453,519,429,099.37,939,676,200.17
分配股利、利润或偿付利息支付的现金494,647,500.64380,273,049.72107,729,509.33766,078,203.06
其中:子公司支付给少数股东的股利、利润86,668,847.5362,567,596.8720,984,762.82117,917,944.46
支付其他与筹资活动有关的现金4,563,231,318.854,031,010,044.121,313,383,536.5410,989,625,596.82
筹资活动现金流出平衡项目0000
筹资活动现金流出小计18,021,629,538.311,545,030,494.294,940,542,145.1719,695,380,000.05
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-131,026,726.28-17,392,048.74121,377,969.99322,102,593.38
四、汇率变动对现金及现金等价物的影响2,011.522,013.62--
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额-239,957,901.02-57,043,684.98178,380,466.94-17,326,218.52
加:期初现金及现金等价物余额962,502,319.86962,502,319.86962,502,319.86979,828,538.38
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额722,544,418.84905,458,634.881,140,882,786.8962,502,319.86
补充资料:
净利润-163,977,562.12--992,131,349.26
资产减值准备-21,898,572.31-883,823,188.01
固定资产和投资性房地产折旧-71,556,348.6-137,002,132.79
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-71,556,348.6-137,002,132.79
无形资产摊销-18,776,713.53-37,187,974.46
长期待摊费用摊销-13,568,937.84-22,594,353.84
处置固定资产、无形资产和其他长期资产的损失--544,973.44--11,330,111.98
公允价值变动损失--425,930.5--56,846,924.38
财务费用-430,468,506.4-930,858,502.07
投资损失--24,393,439.49-143,504,603.62
递延所得税-2,303,268.35--88,379,190.53
其中:递延所得税资产减少-2,980,368.95--86,656,855.25
递延所得税负债增加--677,100.6--1,722,335.28
存货的减少-498,649,880--401,865,874.47
经营性应收项目的减少--631,114,390.17--449,982,333.01
经营性应付项目的增加--384,938,255.95--320,727,941.91
融资租入固定资产---77,523,038.51
现金的期末余额---962,502,319.86
减:现金的期初余额---979,828,538.38
加:现金等价物的期末余额-905,458,634.88--
减:现金等价物的期初余额-962,502,319.86--
公告日期2023-10-302023-08-292023-04-282023-04-28
审计意见(境内)标准无保留意见
TOP↑